financetom
Business
financetom
/
Business
/
Coinbase Glb Unusual Options Activity For September 20
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Coinbase Glb Unusual Options Activity For September 20
Sep 20, 2024 10:48 AM

Deep-pocketed investors have adopted a bullish approach towards Coinbase Glb , and it's something market players shouldn't ignore. Our tracking of public options records at Benzinga unveiled this significant move today. The identity of these investors remains unknown, but such a substantial move in COIN usually suggests something big is about to happen.

We gleaned this information from our observations today when Benzinga's options scanner highlighted 28 extraordinary options activities for Coinbase Glb. This level of activity is out of the ordinary.

The general mood among these heavyweight investors is divided, with 50% leaning bullish and 42% bearish. Among these notable options, 7 are puts, totaling $669,860, and 21 are calls, amounting to $2,660,141.

Expected Price Movements

Analyzing the Volume and Open Interest in these contracts, it seems that the big players have been eyeing a price window from $145.0 to $420.0 for Coinbase Glb during the past quarter.

Volume & Open Interest Development

Looking at the volume and open interest is a powerful move while trading options. This data can help you track the liquidity and interest for Coinbase Glb's options for a given strike price. Below, we can observe the evolution of the volume and open interest of calls and puts, respectively, for all of Coinbase Glb's whale trades within a strike price range from $145.0 to $420.0 in the last 30 days.

Coinbase Glb 30-Day Option Volume & Interest Snapshot

Significant Options Trades Detected:

Symbol PUT/CALL Trade Type Sentiment Exp. Date Ask Bid Price Strike Price Total Trade Price Open Interest Volume
COIN CALL TRADE BEARISH 05/15/26 $71.9 $71.75 $71.75 $150.00 $358.7K 5.3K 209
COIN CALL TRADE BEARISH 05/15/26 $72.85 $71.75 $71.75 $150.00 $358.7K 5.3K 114
COIN CALL TRADE BEARISH 05/15/26 $72.9 $71.75 $71.75 $150.00 $358.7K 5.3K 64
COIN CALL TRADE BULLISH 05/15/26 $71.9 $70.2 $71.75 $150.00 $258.3K 5.3K 295
COIN PUT SWEEP BULLISH 12/20/24 $18.5 $18.25 $18.25 $160.00 $182.5K 1.3K 100

About Coinbase Glb

Founded in 2012, Coinbase is the leading cryptocurrency exchange platform in the United States. The company intends to be the safe and regulation-compliant point of entry for retail investors and institutions into the cryptocurrency economy. Users can establish an account directly with the firm, instead of using an intermediary, and many choose to allow Coinbase to act as a custodian for their cryptocurrency, giving the company breadth beyond that of a traditional financial exchange. While the company still generates the majority of its revenue from transaction fees charged to its retail customers, Coinbase uses internal investment and acquisitions to expand into adjacent businesses, such as prime brokerage and data analytics.

Present Market Standing of Coinbase Glb

Currently trading with a volume of 3,642,568, the COIN's price is up by 1.81%, now at $171.29.

RSI readings suggest the stock is currently may be approaching oversold.

Anticipated earnings release is in 41 days.

Professional Analyst Ratings for Coinbase Glb

1 market experts have recently issued ratings for this stock, with a consensus target price of $169.0.

Unusual Options Activity Detected: Smart Money on the Move

Benzinga Edge's Unusual Options board spots potential market movers before they happen. See what positions big money is taking on your favorite stocks. Click here for access.

* An analyst from Barclays has elevated its stance to Equal-Weight, setting a new price target at $169.

Trading options involves greater risks but also offers the potential for higher profits. Savvy traders mitigate these risks through ongoing education, strategic trade adjustments, utilizing various indicators, and staying attuned to market dynamics. Keep up with the latest options trades for Coinbase Glb with Benzinga Pro for real-time alerts.

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
NCR Voyix Posts Q4 Adjusted Earnings Above Analysts Estimates; Revenue Falls; 2025 Guidance Set
NCR Voyix Posts Q4 Adjusted Earnings Above Analysts Estimates; Revenue Falls; 2025 Guidance Set
Feb 27, 2025
09:35 AM EST, 02/27/2025 (MT Newswires) -- NCR Voyix ( VYX ) reported Q4 non-GAAP earnings Thursday of $0.22 per diluted share. The year-earlier figure was not provided. Analysts polled by FactSet expected $0.11 per share. Revenue for the quarter ended Dec. 31 was $682 million, down from $796 million a year earlier. No comparable revenue estimates were available. NCR...
Kymera Therapeutics Q4 Net Loss Widens, Collaboration Revenue Falls
Kymera Therapeutics Q4 Net Loss Widens, Collaboration Revenue Falls
Feb 27, 2025
08:53 AM EST, 02/27/2025 (MT Newswires) -- Kymera Therapeutics ( KYMR ) reported a Q4 net loss Thursday of $0.88 per diluted share, wider than the loss of $0.25 a year earlier. Analysts polled by FactSet expected a loss of $0.86. Collaboration revenue for the quarter ended Dec. 31 was $7.4 million, down from $47.9 million a year earlier. Analysts...
US House panel subpoenas tech giants over foreign communications
US House panel subpoenas tech giants over foreign communications
Feb 27, 2025
WASHINGTON, Feb 27 (Reuters) - The U.S. House Judiciary Committee has subpoenaed eight major technology companies, including Alphabet, Meta, Apple ( AAPL ) and X Corp, seeking details about their communications with other countries regarding compliance with laws impacting speech, it said on Thursday. House Judiciary Committee Chairman Jim Jordan, a Republican, sent the subpoenas on Wednesday and also included...
Dyne Therapeutics Q4 Net Loss Narrows; Shares Rise
Dyne Therapeutics Q4 Net Loss Narrows; Shares Rise
Feb 27, 2025
09:41 AM EST, 02/27/2025 (MT Newswires) -- Dyne Therapeutics ( DYN ) shares were up 1.7% in early trading Thursday after the company reported a Q4 net loss of $0.88 per diluted share, compared with a $1.09 loss a year earlier. Analysts polled by FactSet expected a $0.94 loss. The company did not report revenue for the quarter ended Dec....
Copyright 2023-2026 - www.financetom.com All Rights Reserved